Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.3 USD
-0.26%
Market Closed
Updated:
May 13, 2024
Taro Pharmaceutical Industries Ltd
Pre-Tax Income
|
Taro Pharmaceutical Industries Ltd
Pre-Tax Income Peer Comparison
Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Pre-Tax Income
$74.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-16%
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Pre-Tax Income
-$624m
|
CAGR 3-Years
48%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Pre-Tax Income
₪5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Pre-Tax Income
-$6.5m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Pre-Tax Income
-₪6.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Pre-Tax Income
-₪5.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Pre-Tax Income?
Pre-Tax Income
74.3m
USD
74.3m
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Pre-Tax Income amounts to 74.3m USD.
What is Taro Pharmaceutical Industries Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-16%
-16%
Over the last year, the Pre-Tax Income growth was 64%.
You don't have any saved screeners yet
